2016 Issue 3: The cancer issue
Researchers at Queen’s run the world’s first clinical trial using immunotherapy to fight early-stage lung cancer.
Young investigators team up with mentors to take on the most pressing questions in cancer research.
Karen Nicole Smith, community outreach coordinator for the Standardized Patient Program at Queen’s University, advocate for others as a person living with a serious illness.
The Canadian Cancer Trials Group at Queen’s plays a central role in the progress of cancer care
Michael Brundage, director of the Division of Cancer Care and Epidemiology for the Queen’s Cancer Research Institute
Annette Hay, senior investigator in the Cancer Clinical Trials Division, Queen’s Cancer Research Institute
Following the completion of their cancer treatment, people living with cancer move into a new phase, of survivorship care.
The discovery, by a Queen's researcher, of an immune-based biomarker will influence treatment options for women with ovarian cancer
John Lynch and Merv Daub remember a friend, colleague and coach in Doug Hargreaves.